Skip to content
Drug recall · FDA · Published October 4, 2023

SUN PHARMACEUTICAL INDUSTRIES INC recalls Bupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets bottle, Rx Only, Distributed by: Sun

Sun Pharmaceutical recalls 150mg Bupropion Hydrochloride Extended-Release Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact Sun for details.

🇺🇸 FDA recall #D-0044-2024DrugSun Pharmaceutical ›
Take action

Contact the company & request your remedy

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way, N/A · Princeton, NJ 08540-6620
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sun Pharmaceutical is recalling 150mg Bupropion Hydrochloride Extended-Release Tablets because they failed dissolution specifications. This could mean the medication doesn't work as intended, so affected users should check their prescription details. Read more at govinfonow.com/recall/33066-sun-pharmaceutical-bupropion-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/33066-sun-pharmaceutical-bupropion-tablets-recall-failed-dissolution-specifications · Updated September 23, 2026 · FDA enforcement record: FDA #D-0044-2024

Cite this page

“Sun Pharmaceutical Bupropion Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33066-sun-pharmaceutical-bupropion-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0044-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0044-2024%22&limit=1).

Why it’s dangerous

The tablets failed to dissolve properly as required by the manufacturer's specifications. This could lead to inconsistent medication levels in the body, potentially affecting treatment effectiveness. However, the recall does not indicate immediate safety risks like injury or death.

Who’s affected

Prescription users of the 150mg Bupropion Hydrochloride Extended-Release Tablets (NDC 47335-737-86) who received the batch with lot number HAD0360A. People taking this medication for depression or anxiety are most at risk.

How to tell if you have this one

Check for the product name 'Bupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets bottle' with NDC 47335-737-86 and lot number HAD0360A. This product was distributed by Sun Pharmaceutical Industries, Inc. in the US.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Prescription Details

    Verify if your prescription matches the recalled product: 150mg Bupropion Hydrochloride Extended-Release Tablets, NDC 47335-737-86, lot HAD0360A.

✎ GovInfoNow

Questions people ask

Is this product dangerous?

The recall is for failed dissolution specifications, which may affect medication effectiveness but does not indicate immediate safety risks like injury or death.

How do I know if I have the recalled product?

Check the product label for NDC 47335-737-86 and lot number HAD0360A. This product was distributed by Sun Pharmaceutical Industries, Inc. in the US.

What should I do if I have the recalled product?

The recall does not specify a remedy, so contact Sun Pharmaceutical Industries for further instructions.

Take action

Contact Sun Pharmaceutical

We’ve drafted a message you can send Sun Pharmaceutical to request your refund or repair — edit it as you like.

Subject: Recall D-0044-2024 — Sun Pharmaceutical Sun Pharmaceutical

Hello,

I own a Sun Pharmaceutical that is covered by recall D-0044-2024 from Sun Pharmaceutical.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0044-2024 (October 4, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0044-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA